CRON 2.08 (+1.46%)
CA22717L1013Drug ManufacturersDrug Manufacturers - Specialty & Generic

Cronos Group (CRON) Competitor Comparison

We are evaluating the key criteria listed to compare Cronos Group (CRON) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - CRON ranking 29 / 54

These are the competitors of Cronos Group in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Green Thumb Industries R9U2.F
46.47
2. Phibro Animal Health PAHC
37.71
3. ProPhase Labs PRPH
32.25
4. Catalent CTLT
23.28
5. ANI Pharmaceuticals ANIP
19.04
6. Evolus EOLS
15.35
7. Organogenesis Holdings ORGO
13.9
8. Regencell Bioscience Holdings RGC
13.48
9. Kamada KMDA
9.26
10. Neoleukin Therapeutics NLTX
8.58
11. Alimera Sciences ALIM
7.82
12. Vifor Pharma G2AB.F
7.23
13. Alvotech ALVO
6.58
14. PetIQ PETQ
6.43
15. Zoetis ZTS
5.22
16. Kolinpharma KIP.MI
4.88
17. Collegium Pharmaceutical COLL
4.59
18. Curaleaf Holdings CURLF
4.59
19. Linc LNC
4.46
20. Perrigo PRGO
4.34
21. Pacira BioSciences PCRX
4.28
22. Elanco Animal Health ELAN
3.94
23. Ayr Wellness 3KJB.F
3.71
24. Taro Pharmaceutical Industries TARO
3.55
25. Ironwood Pharmaceuticals IRWD
3.44
26. Supernus Pharmaceuticals SUPN
3.33
27. Avadel Pharmaceuticals AVDL
3.18
28. Journey Medical DERM
2.92
29. Cronos Group CRON
2.83
30. Emergent BioSolutions EBS
2.73
31. Bausch Health Companies BHC
2.59
32. Procaps Group PROC
2.59
33. Embecta EMBC
2.56
34. Zynerba Pharmaceuticals ZYNE
2.47
35. Cumberland Pharmaceuticals CPIX
2.43
36. Relmada Therapeutics RLMD
2.41
37. Jupiter Wellness JUPW
2.39
38. Theratechnologies THTX
2.34
39. Teva Pharmaceutical Industries TEVA
2.23
40. Societal CDMO SCTL
2.21
41. Eagle Pharmaceuticals EGRX
2.19
42. Solid Biosciences SLDB
2.01
43. Alpha Teknova TKNO
1.98
44. SCYNEXIS SCYX
1.93
45. Clever Leaves Holdings CLVR
1.87
46. OptiNose OPTN
1.83
47. Ascend Wellness Holdings AAWH
1.77
48. Tilray Brands TLRY
1.77
49. Biofrontera BFRI
1.74
50. Flora Growth FLGC
1.63
51. Universe Pharmaceuticals UPC
1.61
52. Amphastar Pharmaceuticals AMPH
1.51
53. Amneal Pharmaceuticals AMRX
0.93
54. Harrow Health HROW
0.42

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.